Deskripsi
Lipidomic analysis showing changes in mitochondria-associated membrane (MAM) lipid composition following mitotane treatment. Alterations in phospholipid and sterol profiles indicate MAM dysfunction.
Figure 2
ChartSource Paper
Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches.Cite This Figure
![Figure 2: Lipidomic analysis showing changes in mitochondria-associated membrane (MAM) lipid composition following mitotane treatment. Alterations in phospholipid and sterol profiles indicate MAM dysfunction.]() > Source: Ségolène Hescot et al. "Identifying mitotane-induced mitochondria-associated membranes dysfunctions: met." *Oncotarget*, 2017. PMID: [29299119](https://pubmed.ncbi.nlm.nih.gov/29299119/)
<figure> <img src="" alt="Lipidomic analysis showing changes in mitochondria-associated membrane (MAM) lipid composition following mitotane treatment. Alterations in phospholipid and sterol profiles indicate MAM dysfunction." /> <figcaption>Figure 2. Lipidomic analysis showing changes in mitochondria-associated membrane (MAM) lipid composition following mitotane treatment. Alterations in phospholipid and sterol profiles indicate MAM dysfunction.<br> Source: Ségolène Hescot et al. "Identifying mitotane-induced mitochondria-associated membranes dysfunctions: met." <em>Oncotarget</em>, 2017. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29299119/">29299119</a></figcaption> </figure>